TEXT

Top Abstract Text References

The genomes of cytomegaloviruses (CMVs) comprise approximately 180 open reading frames (ORFs) (12, 22), several of which are homologous to genes of the host organism. Most of these ORFs are suspected to interfere with the immune system of the host and encode putative chemokines and chemokine receptors. In addition, genes homologous to mammalian major histocompatibility complex (MHC) class I genes have been identified within the genomes of two CMV species: human CMV (HCMV) (1) and murine CMV (MCMV) (22). In this report, we present the identification and characterization of a third herpesvirus gene putatively encoding an MHC class I homolog, the rat CMV (RCMV) r144 gene.

Identification, cloning, and sequence analysis of the RCMV r144 gene. Previously, it was shown that the majority of RCMV genes are colinear with genes of both HCMV and MCMV (2-5, 29, 30). However, the genes of HCMV and MCMV encoding MHC class I homologs (UL18 and m144, respectively) are localized within dissimilar regions of their respective genomes (12, 22). Since previously described RCMV genes were found to share more sequence similarity with the corresponding genes of MCMV than with those of HCMV (2-5), we hypothesized that a putative RCMV gene homologous to MHC class I genes would be located in a genomic region similar to that of MCMV m144. Accordingly, we focused on a 20-kb region of the RCMV genome spanning from the EcoRI fragment to the XbaI P fragment (Fig. 1A) (20). As shown in Fig. 1A, an ORF (r144) having significant similarity to the MCMV m144 gene was identified within this region. The RCMV r144 ORF has a length of 963 bp and potentially encodes a 321-amino-acid polypeptide with a predicted molecular mass of 36 kDa. The sequence of this polypeptide shows 30 and 19% similarity with the amino acid sequences encoded by MCMV m144 and HCMV UL18, respectively. The predicted amino acid sequence of the r144-encoded protein (gpr144) was compared with sequences from a representative set of mammalian MHC class I polypeptides as well as with the amino acid sequences derived from MCMV m144 and HCMV UL18 (gpm144 and gpUL18, respectively). The sequences of these polypeptides were included in a CLUSTAL W multiple alignment (Fig. 1B). The alignment shows four cysteine residues to be conserved between gpr144, gpm144, gpUL18, and mammalian MHC class I polypeptides. These conserved cysteines, which might play a role in disulfide bridge formation (7), are located at positions 111, 139, 176, and 235 of gpr144. Within the gpr144 sequence, three putative N-linked glycosylation sites are present. One of these sites, at positions 95 to 97, is positionally conserved between gpr144, gpm144, and mammalian MHC class I proteins. Based on the alignment shown in Fig. 1B, the putative r144 gene product, as well as the UL18- and m144-encoded proteins, can be assigned a domain structure similar to that previously determined for human HLA-A2. The HLA-A2 protein was found to consist of six domains, as follows: (i) a putative N-terminal leader sequence, (ii) an 1 domain, (iii) an 2 domain, (iv) an immunoglobulin-like 3 domain, (v) a putative transmembrane -helix region, and (vi) a short intracellular region (7). It was previously shown that gpm144 shows a considerable deletion within its putative 2 region compared to the 2 region of mammalian MHC class I molecules (11). Interestingly, gpr144 has a similar deletion within its putative 2 domain, whereas the corresponding region of gpUL18 comprises several small insertions relative to mammalian MHCs (11) (Fig. 1B). The 1 and 2 regions of mammalian class I proteins were demonstrated to form a groove for binding small antigenic peptides to be presented on the cell surface (6). The loss of sequences within the corresponding regions of gpm144 may account for the inability of this protein to form a complex with peptides, in contrast to HCMV gpUL18 (11). Considering the sequence similarity between gpr144 and gpm144, gpr144 might similarly be unable to bind peptides. In order to show the relationship between the sequences of all known virus-encoded MHC class I homologs and those of several mammalian MHC class I molecules, a phylogenetic tree was constructed (Fig. 1C). This tree shows that the mammalian MHC class I molecules represent the most conserved group of sequences, whereas the virus-encoded homologs are relatively divergent. Most notably, the phylogenetic distances between the gpUL18 sequence and the gpr144, the gpm144, and the poxvirus MHC-like sequences (gpMC1080R and gpMC2080R) are similar. This suggests that the incorporation of a UL18-like gene into an ancestral genome of HCMV on the one hand and the incorporation of an r144- or m144-like gene in an ancestral genome of both RCMV and MCMV on the other hand were independent evolutionary events. This theory is underscored by the observation that the relative position of UL18 within the HCMV genome differs from those of both r144 and m144 within their respective genomes.

View larger version (61K): [in this window] [in a new window]   FIG. 1.   The RCMV r144 gene encodes an MHC class I homolog. (A) Restriction map of the RCMV (strain Maastricht) genome (20) and the relative position of the r144 gene, which putatively encodes an MHC class I homolog. A section of this map has been enlarged below the main map. White arrow boxes indicate the size and polarity of the RCMV ORFs surrounding the r144 ORF (hatched). (B) To compare the sequences of viral MHC class I-like and mammalian MHC class I proteins, a CLUSTAL W (28) multiple sequence alignment was generated. In the alignment, a PAM250 protein distance matrix was included (pairwise alignment gap penalty = 3, multiple alignment gap penalty = 10, gap extension penalty = 10). Signal peptides, transmembrane domains, and potential glycosylation sequences (NX[T/S]) are enclosed in white boxes. Conserved cysteine residues, potentially engaged in disulphide bridge formation, are enclosed in black boxes. A schematic representation of the secondary peptide structure is shown below the sequences. -Helices are indicated by black arrows, and -sheets are indicated by white arrows. The positions of these structures were derived from an entry of the Brookhaven protein structure database (PDB) (http://www.ncbi.nlm.nih.gov/Structure/index.html), containing the structure of recombinant HLA-A2 (7). The alignment includes gpr144, gpm144 (22), gpUL18 (1), and three mammalian MHC class I proteins, rat RT1.A1 (17), murine H2-Kd (18), and human HLA-A2 (7, 16). We defined the putative gene products of r144, m144, and UL18 as gpr144, gpm144, and gpUL18, respectively. The prefix gp (glycoprotein) was used to address the potential glycosylated state of these putative gene products. (C) A phylogenetic tree of all known virus-encoded class I MHC homologs and three mammalian MHC class I proteins. The tree was based on a multiple sequence alignment of the complete predicted amino acid sequences of gpr144, gpm144, gpUL18, molluscum contagiosum virus (MCV) type 1 and type 2 MC080R (25, 26), RT1.A1, H2-Kd, and HLA-A2. The alignment parameters were similar to those described for panel A.

Generation of an RCMV r144 null mutant. To investigate the role of r144 in RCMV replication, we constructed a recombinant RCMV strain (RCMVr144), in which the r144 gene was partially deleted and replaced by the neo gene (Fig. 2A). Subsequent to plaque purification, the clonal purity and integrity of the recombinant strain were confirmed by restriction endonuclease digestions in combination with Southern blot analysis (data not shown). To investigate the effect of disruption of the r144 gene on transcription of its neighboring genes, poly(A)⁺ RNA isolated from RCMV-, RCMVr144-, and mock-infected primary rat embryo fibroblasts (REF) was subjected to Northern analysis. This indicated that there are no significant differences between RCMVr144 and WT virus in transcription of ORFs neighboring r144 (data not shown). Notably, transcripts of r144 could not be detected by Northern blotting either in RCMV- or in RCMVr144-infected REF. Similarly, transcription of m144 has not been demonstrated in MCMV-infected cells.

View larger version (20K): [in this window] [in a new window]   FIG. 2.   Construction of an RCMV strain in which the r144 gene is disrupted. (A) The RCMV genome, of which the part containing the r144 ORF is shown, was modified by homologous recombination with a recombination plasmid, p081, resulting in recombinant strain RCMVr144. The recombination plasmid was constructed as follows. First, the genomic RCMV DNA fragments XbaI H and EcoRI O (Fig. 1A) were cloned into pUC119 to generate plasmids pRXH and pREO, respectively. Then a 2.0-kb DNA fragment was deleted from pRXH by treatment with Asp718I. The remaining 7.1-kb fragment was circularized by incubation with T4 DNA ligase (Pharmacia Biotech, Roosendaal, The Netherlands), resulting in plasmid pA. Subsequently, a 2.4-kb SphI-XbaI fragment derived from pREO was ligated into SphI-XbaI-digested plasmid pA, thereby generating plasmid pB. A 1.5-kb BamHI-EcoRI fragment from Rc/CMV (Invitrogen, Leek, The Netherlands), containing the neomycin resistance gene (neo), was treated with DNA polymerase I Klenow fragment (Pharmacia Biotech) and ligated into XbaI-digested and Klenow fragment-treated plasmid pB, resulting in plasmid p081. ORFs are shown as arrow boxes. WT and mutated r144 sequences are indicated with descending hatches. The neo gene is indicated with ascending hatches. (B) The r144 gene is dispensable for primary RCMV infection in vivo. Four-week-old male specific-pathogen-free Lewis/N RT1 rats (Central Animal Facility, University of Maastricht, Maastricht, The Netherlands) were immunosuppressed 1 day before infection by 5 Gy of total-body Röntgen irradiation, as described by Stals et al. (27). Intraperitoneal infection was carried out with 106 PFU of either WT RCMV () or RCMVr144 (). All virus stocks that were used for inoculation in vivo were derived from tissue culture medium of virus-infected REF. The number of surviving rats was recorded daily until day 28 p.i.

Replication characteristics of RCMVr144 in vitro. To compare the replication characteristics of RCMVr144 with those of WT RCMV in vitro, we infected three different cell types with these viruses and determined the percentage of infected cells at various time points after infection, in a manner similar to that described previously (2, 4). In addition, the amount of infectious virus that was produced by each cell type was investigated. The cell types tested included REF, rat heart endothelium cell line 116 (31), and monocyte and macrophage cell line R2 (14). We found that the percentage of infected cells did not differ significantly between WT RCMV- and RCMVr144-infected cells, irrespective of the cell type. Moreover, no significant differences between WT and recombinant viruses in the virus titers produced by each cell type were observed (data not shown). These data indicated that r144 is not essential for RCMV replication in these cell types in vitro. Similar results have previously been reported for both the HCMV strain with a deletion of the UL18 gene (8) and the MCMV strain with a deletion of the m144 gene (15).

In vivo RCMVr144 infection. Infection of immunocompetent rats with RCMV generally results in asymptomatic infections in which the virus can be detected almost exclusively in the salivary glands (9). By contrast, RCMV infection of immunocompromised animals usually leads to disease in which viral replication can be observed in many organs and tissues of the rats (2, 4, 9, 27). Consequently, in order to investigate the role of r144 in the pathogenesis of RCMV disease, we infected rats with either WT RCMV or RCMVr144 after the induction of immunosuppression by total-body Röntgen irradiation. In an initial experiment, two groups of 4-week-old, immunosuppressed rats (five animals per group) were inoculated with 10⁶ PFU of either WT RCMV or RCMVr144. The number of surviving rats in each group was monitored until day 28 postinfection (p.i.). Surprisingly, no significant difference in the survival rate of groups of rats infected with either WT RCMV or recombinant virus was seen (Fig. 2B). In order to compare the dissemination of RCMVr144 with that of WT RCMV, we infected two groups of 10-week-old, immunosuppressed rats (five animals per group) with 5 × 10⁶ PFU of either WT RCMV or RCMVr144. At days 4 and 21 p.i., the presence of virus in several internal organs was determined by both plaque assay and immunohistochemistry, in a manner similar to that described previously (2, 4, 9). As summarized in Table 1, no significant differences between WT RCMV and RCMVr144 in tissue distribution or titers of virus were observed at either day 4 or day 21 p.i. To exclude the possibility of RCMVr144 being overgrown by WT RCMV in vivo, due to either contamination or insufficient plaque purification, infectious virus was recovered from salivary glands of WT virus- and recombinant virus-infected rats at day 21 p.i. by cell culture. DNA was isolated from extracellular virions and subsequently analyzed by Southern blot hybridization. As expected, the results illustrated the integrity of the genomes of both WT and recombinant virus (data not shown).

View this table: [in this window] [in a new window]   TABLE 1.   Dissemination of WT RCMV and RCMVr144 in various organs of infected, immunocompromised rats

Dissemination of RCMVr144 on day 330 p.i. Although differences between WT and recombinant virus were not seen during the acute phase of infection, we considered the possibility that disruption of the RCMV r144 gene might have an effect on long-term persistent or latent infection of rats. We therefore investigated dissemination of RCMV and RCMVr144 at a late stage of infection. Thus, two groups of 6-week-old, immunosuppressed rats (five animals per group) were infected with 10⁶ PFU of either RCMV or RCMVr144. On day 330 p.i., total cellular DNA was purified from various tissues and organs of the rats using an XTRAX DNA extraction kit (Gull Laboratories, Salt Lake City, Utah). Then the DNA samples were subjected to a sensitive, single-tube, nested PCR that enables amplification of part of the major immediate-early region of the RCMV genome (3). The PCR mixtures (50 µl) contained 1 µg of target DNA, 0.05 µM concentrations of primers RIE3F (5'-CCA GAG TGA CGT TGC AGA TGT TGG AAA TCA-3'; nucleotides 3425 to 3454 of the sequence assigned GenBank accession no. AF046125) and RIE3R2 (5'-GGT CAC GAC CCT GCT GCC GTC TAG GT-3'; complement of nucleotides 3719 to 3744 of the sequence assigned GenBank accession no. AF046125), 1 µM concentrations of primers RIE4F (5'-ATG AAA TGG TGA TGA GAT-3'; nucleotides 3461 to 3478 of the sequence assigned GenBank accession no. AF046125) and RIE4R (5'-CTT CTA GTG ATT TGG CAT-3'; complement of nucleotides 3686 to 3707 of the sequence assigned GenBank accession no. AF046125), 100 µM concentrations of each deoxynucleoside triphosphate, 1.25 U of HotStar Taq DNA polymerase (Qiagen, Leusden, The Netherlands), and HotStar Taq DNA polymerase buffer (Qiagen). Amplification was performed with a GeneAmp PCR System 9600 thermal cycler (Perkin-Elmer, Nieuwerkerk aan de Ijssel, The Netherlands), which was programmed to incubate the samples for 15 min at 95°C, followed by 30 cycles of 30 s at 95°C, 30 s at 70°C, and 30 s at 72°C and 25 cycles of 30 s at 95°C, 30 s at 55°C, and 30 s at 72°C. Finally, the tubes were incubated for 5 min at 72°C. PCR products were analyzed by agarose gel electrophoresis and ethidium bromide staining. This procedure enabled detection of 1 to 10 copies of genomic RCMV DNA per µg of organ tissue (1 to 10 RCMV genome copies per 2.4 × 10⁵ cells) (data not shown). As shown in Table 1, DNA from both WT RCMV and RCMVr144 was detected in a similar spectrum of organs of infected rats. Virus DNA was detected most consistently in the salivary glands and the liver (Table 1), irrespective of whether rats were infected with WT RCMV or RCMVr144. Interestingly, virus DNA could be detected in the spleen of four of five RCMVr144-infected rats, whereas spleen tissue from three of three WT RCMV-infected rats was PCR negative. This difference is, given the variation in viral DNA load among infected rats (data not shown) and the limited number of animals tested (two of five animals from the WT RCMV-infected group died during the course of the experiment), not significant. In a follow-up experiment, in which larger groups of animals are used, potential differences between WT RCMV and RCMVr144 in the viral DNA load within organs of latently infected rats will have to be investigated further.

Infection of rat footpads with RCMVr144. Previously, Persoons et al. (21) described a model for local RCMV infection in which the footpad of immunosuppressed rats is inoculated with virus. As a result of this infection, severe macro- and microscopic pathology can be seen, including paw thickening, ballooning of endothelial cells, adherence of polymorphonuclear and mononuclear cells to the endothelial surface, and infiltration of inflammatory cells into the perivascular area (21). We employed this model to compare WT RCMV and RCMVr144 in the pathology induced by local infection with these viruses. Groups of 6-week-old, immunosuppressed rats (five animals per group) were injected subcutaneously with 10⁵ PFU of either WT RCMV or RCMVr144 in the dorsum of the right hind paw, in a manner similar to that described previously (21). As a control, supernatant from mock-infected REF cultures was injected in the left hind paw of the rats. The thickness of the rat paws was measured daily, as described by Persoons et al. (21). In a separate, similar experiment, rats were sacrificed at either day 4, day 8, or day 15 after infection and sections (4 µm) of the paws were investigated for the presence of infiltrating leukocytes by using leukocyte subset-specific monoclonal antibodies. As described previously (21), infection of rat footpads with RCMV resulted in thickening of the paws. Similar macroscopic alterations were observed after infection with RCMVr144, whereas changes in the mock-infected paws were not detected (data not shown). Interestingly, we found significant differences between WT RCMV and RCMVr144 in the number of infiltrating leukocytes in the infected paws. At day 15 p.i., a significantly lower number of macrophages was detected in RCMVr144-infected paws than in RCMV-infected paws (Fig. 3A). In accordance with this, significantly lower numbers of cells expressing VLA-4 (Fig. 3B), LFA-1 (data not shown), and CD4 (Fig. 3C) were detected in RCMVr144-infected paws than in WT RCMV-infected paws at day 15 p.i. VLA-4, LFA-1, and CD4 can be expressed on the surface of various subsets of leukocytes, including monocytes and macrophages. Also, a small but significant difference between recombinant virus- and WT virus-infected paws in the number of CD8⁺ cells (means ± standard errors of the means, 111 ± 11 and 152 ± 9, respectively) was observed at day 15 p.i. Although CD8 can be expressed on both NK cells and a subset of T lymphocytes, it is likely that the CD8⁺ cells do not represent NK cells, since in the number of NK cells RCMVr144- and WT RCMV-infected paws did not significantly differ (Fig. 3D). It is possible that the observed differences in leukocyte influx resulted from differences in replication between RCMV and RCMVr144. However, both viruses were found to have similar replication characteristics in the rat paws, as judged by similar viral DNA loads as well as similar expression levels of RCMV early proteins (data not shown). Taken together, our data indicate that a higher number of macrophages and CD8⁺ T cells infiltrate in WT virus- than in RCMVr144-infected rat paws. This suggests that the r144-encoded protein might play a role, either directly or indirectly, in the interaction with macrophages and CD8⁺ T cells rather than NK cells. Interestingly, our findings may provide support for the hypothesis of Leong et al. that viral MHC class I homologs may be more important in affecting monocyte and dendritic cell function than in affecting NK cell function (19). This hypothesis was based on results of Cosman and coworkers (13), who found that the HCMV UL18 gene product can interact with a membrane receptor, designated ILT2 (24) or LIR-1 (13), which is predominantly expressed on monocytes and B lymphocytes. Since ILT2/LIR-1 is expressed on only a minor subset of NK cells (13), the physiological significance of the interaction of gpUL18 with this receptor on NK cells is unclear. Leong et al. hypothesized that the interaction of gpUL18 with ILT2/LIR-1 on monocytes or dendritic cells could suppress IL12 production, which would limit the secretion of gamma interferon by NK cells, thereby altering the early immune response (19). Such a mechanism could also explain the severely restricted replication of the MCMV m144 knockout virus in vivo (15).

View larger version (22K): [in this window] [in a new window]   FIG. 3.   Infection of rat footpads with either RCMV or RCMVr144. Six-week-old, immunosuppressed rats were injected subcutaneously with 105 PFU of either WT RCMV () or RCMVr144 () in the dorsum of the right hind paw, as described previously (21). Rats were sacrificed at either day 4, day 8, or day 15 after infection. Sections (4 µm) of the hind paws were investigated by indirect immunohistochemistry with the following monoclonal antibodies: anti-rat CD11b (directed against a macrophage marker protein; clone MRC OX-42; Serotec Ltd., Oxford, United Kingdom) (A), anti-rat CD49d (directed against VLA-4; clone P12520; PharMingen, San Diego, Calif.) (B), anti-rat CD4 (directed against CD4; clone W3/25; Harlan Sera-Lab Ltd., Sussex, United Kingdom) (C), and 323 (directed against NK cells) (10) (D). The number of positively stained cells was determined by counting the number of positive cells per field of view. HPF, high power field. Magnification, ×400. Two independent, representative fields per section were scored. The graphs represent data from a single, representative tissue section. Data are means ± standard errors of means (error bars). The significance of the differences was determined by the Mann-Whitney U-Wilcoxon rank sum W test. P values of 0.05 were considered to indicate statistical significance. Time points at which significant differences between RCMV- and RCMVr144-infected rat hind paws were found are indicated by an asterisk.

Nucleotide sequence accession number. The sequence of the RCMV genome spanning from EcoRI O to XbaI H, which contains the r144 ORF (Fig. 1A), and the predicted amino acid sequence derived from r144 have been deposited in the GenBank database under accession no. AF133339.